Belgium· BE-AMP-SAM106093-00

Parlodel 2.5 mg

A bromocriptine product containing bromocriptine mesilate, registered in Belgium by Exeltis Germany. The same ATC class is registered in 8 of our 19 countries.

ATC N04BC01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedParlodel 2.5 mgATCN04BC01REGISTER NO.BE-AMP-SAM106093-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Bromocriptine is registered in 8 of 19 countries.

Countries holding a registration under ATC N04BC01 (bromocriptine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Bromocriptine · ATC N04BC01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bromocriptine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bromocriptine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • US United States$32.93 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Bromocriptine Mesilate
Manufacturer
Exeltis Germany
Country
Belgium (BE)
ATC code
N04BC01
ATC class
Bromocriptine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0066266
    EUR 14
  • be_apb
    0726257

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for bromocriptine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bromocriptine · interactions on record

92 records

  • 3 severe
  • 87 moderate
  • 2 minor

Most severe, free to view

  • IsomethepteneA03AX10severe
  • LorcaserinA08AA11severe
  • PhenylpropanolaminA08AA13severe
  • LansoprazoleA02BC03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromocriptine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromocriptine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Bulgaria · Бромокриптин Медокеми
  • Cyprus · Medocriptine, Pirodal
  • Czechia · Medocriptine
  • Germany · Pravidel
  • Estonia · Bromocriptin Richter
  • Spain · Parlodel
  • France · Parlodel
  • United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
  • Hungary · Bromocriptin Richter
  • Italy · Parlodel
  • Lithuania · Bromocriptin Richter
  • Luxembourg · Pravidel
  • Latvia · Bromocriptin Richter
  • Malta · Medocriptine
  • Netherlands · Parlodel
  • Norway · Parlodel
  • Poland · Bromocorn
  • Portugal · Bromocriptina Generis, Parlodel
  • Romania · Brocriptin
  • Sweden · Pravidel
  • Slovakia · Medocriptine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dda97112-8fae-4628-a560-83eda249db9a
GET /v1/drugs/dda97112-8fae-4628-a560-83eda249db9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Parlodel 2.5 mg",
  "name_fr": "Parlodel 2.5 mg",
  "name_nl": "Parlodel 2.5 mg",
  "amp_code": "SAM106093-00",
  "strengths": [
    "2.8700",
    "2.8700",
    "2.8700",
    "2.5000",
    "2.5000",
    "2.5000",
    "0.5000",
    "116.3800"
  ],
  "pack_count": 1,
  "substances": [
    "Bromocriptine Mesilate",
    "Bromocriptine",
    "Disodium Edetate",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Bromocriptine",
  "authorisation_numbers": [
    "BE106093"
  ]
}

See everything about bromocriptine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.